[1]Fan JG, Farrell GC.Epidemiology of non-alcoholic fatty liverdisease in China[J].J Hepatol, 2009, 50 (1) :204-210.
|
[2]de Alwis NM, Day CP.Non-alcoholic fatty liver disease:the mist gradually clears[J].J Hepatol, 2008, 48 (Suppl 1) :S104-S112.
|
[3]Farrell GC, Chitturi S, Lau GK, et al.Guidelines for the as-sessment and management of non-alcoholic fatty liver dis-ease in the Asia-Pacific region:executive summary[J].JGastroenterol Hepatol, 2007, 22 (6) :775-777.
|
[4]中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.
|
[5]Zeng MD, Fan JG, Lu LG, et al.Guidelines for the diagnosisand treatment of nonalcoholic fatty liver disease[J].DigDis, 2008, 9 (2) :108-122.
|
[6] 中华医学会.消化道静脉曲张及出血的内镜诊断和治疗规范试行方案 (2009年) [J].中华消化内镜杂志, 2010, 27 (1) :1-4.
|
[7]施丁一, 刘华, 陈健.腹腔积液声像769例特征分析[J].武警医学, 1998, 9 (4) :196-198.
|
[8]Angulo P.GI epidemiology:nonalcoholic fatty liver disease[J].Aliment Pharmacol Ther, 2007, 25 (8) :883-889.
|
[9]Fan JG, Zhu J, Li XJ, et al.Prevalence of and risk factorsfor fatty liver in a general population of Shanghai, China[J].J Hepatol, 2005, 43 (3) :508-514.
|
[10]Fan JG, Saibara T, Chitturi S, et al.What are the risk factorsand settings for non-alcoholic fatty liver disease in Asia-Pacific?[J].J Gastroenterol Hepatol, 2007, 22 (6) :794-880.
|
[11]Farrell GC, Larter CZ.Nonalcoholic fatty liver disease:fromsteatosis to cirrhosis[J].Hepatology, 2006, 43 (2 Suppl1) :S99-S112.
|
[12]徐正婕, 钟妍, 范建高.上海地区494例肝硬化的病因及其与糖代谢异常的关系[J].中华肝脏病杂志, 2009, 17 (6) :470-471.
|
[13]Smith B, Georage J.A dipocyte-hepatocyte crosstalk andthe pathogenesis of nonalcoholic fatty liver disease[J].Hep-atology, 2009, 49 (5) :1765-1767.
|
[14]Lalor PF, Faint J, Aarbodem Y, et al.The role of cytokinesand chemokines in the development of steatohepatitis[J].Seminar in liver disease, 2007, 27 (2) :173-193.
|